SCHEMBL7147535

SCHEMBL7147535

CC(C)(C)OC(=O)Nc1cc(N2CCSCC2)c(C#Cc2ccccc2)cc1[N+](=O)[O-]

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.40
BCL2L2 Q92843 1/20 0.40
MAPT P10636 7/20 0.35
THRB P10828 1/20 0.35
ALDH1A1 P00352 6/20 0.35
HTT P42858 3/20 0.35
MAPK1 P28482 3/20 0.35
NPC1 O15118 1/20 0.35
GLA P06280 1/20 0.35
CASP3 P42574 1/20 0.35
RAB9A P51151 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
NPSR1 Q6W5P4 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KDM4E B2RXH2 1/20 0.34
LMNA P02545 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7145867 0.90 WDR5 (0.44) GRM5MAPTALDH1A1MAPK1NPC1
SCHEMBL7140578 0.89 ALDH1A1 (0.47) MAPTALDH1A1MAPK1RAB9ATDP1
SCHEMBL7139831 0.88 GRM5 (0.39) GRM5MAPTALDH1A1HTTMAPK1
SCHEMBL7142627 0.87 GRM5 (0.38) GRM5MAPTALDH1A1HTTMAPK1
SCHEMBL7703657 0.86 GRM5 (0.34) GRM5MAPTALDH1A1HTTMAPK1
SCHEMBL7145991 0.85 ALDH1A1 (0.44) GRM5MAPTALDH1A1HTTMAPK1
SCHEMBL6437295 0.85 MAPT (0.42) BCL2L2MAPTTHRBALDH1A1HTT
SCHEMBL7140140 0.83 MAPT (0.43) MAPTALDH1A1HTTMAPK1NPC1
SCHEMBL7142921 0.82 NPC1 (0.39) MAPTALDH1A1HTTMAPK1NPC1
SCHEMBL7138026 0.81 MAPT (0.41) MAPTALDH1A1HTTMAPK1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed